Powder: -20°C for 3 years | In solvent: -80°C for 1 year
QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,520.00 | |
50 mg | 8-10 weeks | $ 1,980.00 | |
100 mg | 8-10 weeks | $ 2,500.00 | |
1 mL * 10 mM (in DMSO) | 8-10 weeks | $ 434.00 |
Description | QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM). |
Targets&IC50 | KDM4C:35 nM |
In vitro | QC6352 is an effective KDM4C inhibitor (IC50: 35±8 nM). QC6352 blocks the proliferation and self-renewal of BCSCs. In a concentration-dependent manner QC6352 dramatically decreases the anchorage-independent sphere-forming capacity of BCSC1 and BCSC2. The protein levels of (Epidermal growth factor receptor) EGFR are reduced in both BCSC1 and BCSC2 upon treatment with QC6352 [1][2]. |
In vivo | QC6352 strongly affects tumor growth and the final tumor weight of both BCSC1 and BCSC2 xenografts. QC6352 treatment is well tolerated and does not affect body weight of the mice. Treatment with the KDM4 inhibitor QC6352 blocks BCSC xenograft tumor growth[2]. |
Molecular Weight | 387.47 |
Formula | C24H25N3O2 |
CAS No. | 1851373-36-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (64.52 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
QC6352 1851373-36-8 Chromatin/Epigenetic Histone Demethylase QC 6352 QC-6352 inhibitor inhibit